Raia Drogasil S.A. (BVMF:RADL3)

Brazil flag Brazil · Delayed Price · Currency is BRL
21.86
-0.90 (-3.95%)
Apr 2, 2026, 5:07 PM GMT-3
Market Cap38.20B +13.6%
Revenue (ttm)44.25B +13.8%
Net Income1.30B +8.1%
EPS0.78 +10.0%
Shares Out1.75B
PE Ratio27.96
Forward PE21.47
Dividend0.30 (1.36%)
Ex-Dividend DateDec 8, 2025
Volume15,508,400
Average Volume10,505,490
Open22.13
Previous Close22.76
Day's Range21.59 - 22.50
52-Week Range12.81 - 27.42
Beta0.20
RSI33.62
Earnings DateMay 5, 2026

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil. [Read more]

Sector Healthcare
Founded 1905
Employees 73,895
Stock Exchange Brazil Stock Exchange
Ticker Symbol RADL3
Full Company Profile

Financial Performance

In 2025, Raia Drogasil's revenue was 44.25 billion, an increase of 13.84% compared to the previous year's 38.87 billion. Earnings were 1.30 billion, an increase of 8.08%.

Financial Statements

News

Raia Drogasil SA (RADLY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Shifts

Raia Drogasil SA (RADLY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Shifts

25 days ago - GuruFocus

Q4 2025 Raia Drogasil S/A Earnings Call (English, Portuguese) Transcript

Q4 2025 Raia Drogasil S/A Earnings Call (English, Portuguese) Transcript

25 days ago - GuruFocus